CESAR
MORIS DE LA TASSA
Catedrático de Universidad
Fernando
Rivero Crespo
Publicaciones en las que colabora con Fernando Rivero Crespo (9)
2021
-
Scoring balloon predilation before bioresorbable vascular scaffold implantation in patients with in-stent restenosis: the RIBS VI 'scoring' study
Coronary artery disease, Vol. 32, Núm. 2, pp. 96-104
2020
-
Coronary artery aneurysms, insights from the international coronary artery aneurysm registry (CAAR)
International Journal of Cardiology, Vol. 299, pp. 49-55
-
Lithotripsy-Facilitated Transfemoral Access for Transcatheter Aortic Valve Replacement
CardioVascular and Interventional Radiology
2019
-
Renin-Angiotensin System Inhibition Following Transcatheter Aortic Valve Replacement
Journal of the American College of Cardiology, Vol. 74, Núm. 5, pp. 631-641
2018
-
3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents
JACC: Cardiovascular Interventions, Vol. 11, Núm. 10, pp. 981-991
2017
-
Bioresorbable Vascular Scaffolds for Patients With In-Stent Restenosis: The RIBS VI Study
JACC: Cardiovascular Interventions, Vol. 10, Núm. 18, pp. 1841-1851
-
Usefulness of Drug-Eluting Balloons for Bare-Metal and Drug-Eluting In-Stent Restenosis (from the RIBS IV and V Randomized Trials)
American Journal of Cardiology, Vol. 119, Núm. 7, pp. 983-990
2016
-
Comparison of the Efficacy of Everolimus-Eluting Stents Versus Drug-Eluting Balloons in Patients with In-Stent Restenosis (from the RIBS IV and v Randomized Clinical Trials)
American Journal of Cardiology, Vol. 117, Núm. 4, pp. 546-554
2015
-
Rationale and design of the RIBS IV randomised clinical trial (drug-eluting balloons versus everolimus-eluting stents for patients with drug-eluting stent restenosis)
EuroIntervention, Vol. 11, Núm. 3, pp. 336-342